Gentel Biosciences, a leader in proteomics profiling tools and RayBiotech, Inc., a pioneer and leader in protein and antibody array technologies, jointly announce today their partnership to develop and market RayBiotech's vast collection of antibody array products covering a wide variety of cytokines and other proteins for use with Gentel's APiX™ chromogenic detection platform.
“RayBiotech offers the most comprehensive selection of antibody and protein arrays on the market”
The new kits combine Gentel's APiX™ chromogenic detection technology and RayBiotech, Inc.'s collection of more than 55 antibody and protein arrays on a glass-slide format. Each kit is configured for use with the Gentel Proteomics Multi-System™ and Gentel's AthenaQuant® analysis software for an easy-to-use and cost-effective alternative to fluorescent-based detection. APiX chromogenic technology allows for the detection of any biotinylated molecule, generating light grey-to-black spots that are visible to the naked eye and can be scanned with the Gentel Proteomics Multi-System. The all-inclusive, "sample-into-data" workflow empowers both experts and novices with the necessary tools to conduct an experiment and obtain meaningful proteomics data in a single day.
"RayBiotech offers the most comprehensive selection of antibody and protein arrays on the market," says said Alex Vodenlich, Gentel's President and CEO. "Their collection of high-density, mid-density, and quantitative antibody arrays works seamlessly with their available ELISAs and antibody pairs to form a complete biomarker and proteomics workflow from hypothesis generation to validation. Integration with the Gentel Proteomics System and with Gentel's available arrays puts this complete proteomics workflow into a single box."
RayBiotech's glass-based array product line includes arrays targeting up to 500 proteins. These arrays have been featured in hundreds of publications, including research published in Nature (2008; 455; 391-395, Human PDGF-AA), Nature Medicine (2007; 13: 742-747, Mouse G-CSF), Proceedings of the National Academy of Sciences USA (2007; 104: 7438-7443, Mouse CXCL16, SDF-1), FASEB Journal (2009; 23: 351-361, Mouse SDF-1, SCF), and the Journal of Biological Chemistry (2007; 282: 34510-34524). The high quality arrays produced by RayBiotech, enable investigators in their biomedical research, biomarker and drug discovery and development.
Dr. Ray (Ruo-Pan) Huang, founder and President of RayBiotech, Inc. recognized the potential of the Gentel reagents and system for use with RayBiotech's Quantibody®, G-Series, and L-Series arrays. "Our customers are looking for a simple, sensitive, and affordable detection method for use with our array products. The Gentel Proteomics Multi-System and APiX detection meets this need," stated Dr. Huang. "We are excited about how RayBiotech's easy-to-use kits and Gentel's affordable system can help make arrays accessible to whole a new group of users."
These new APiX Antibody Arrays are available for purchase immediately from Gentel and are the third in a series of high-value products and services that Gentel is commercializing in the second half of 2010. As an introduction to the technology, Gentel will provide scanning and spot finding for a limited time free-of-charge using these kits. To learn more about the forty-nine new APiX Antibody Arrays, see how they augment your proteomics-research workflow and find out how to take advantage of the free "scan and report" service offer, please visit www.gentelbio.com/apixantibodyarrays.
Study shows potential for universal flu vaccine with broad antibody response